Publication

Smith AK, Conneely KN, Pace TWW, Mister D, Felger JC, Kilaru V, Akel MJ, Vertino PM, Miller AH, Torres MA. 2014. Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun. 38:227–36. doi:10.1016/j.bbi.2014.02.010.

Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WPD, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, et al. 2014. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 46:427–9. doi:10.1038/ng.2928.

Abbas M, Shanmugam I, Bsaili M, Hromas R, Shaheen M. 2014. The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination. J Biol Chem. 289:14009–19. doi:10.1074/jbc.M113.520056.

Braun KL, Tsark JU, Powers A, Croom K, Kim R, Gachupin FC, Morris P. 2014. Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank. 12:106–12. doi:10.1089/bio.2013.0083.

Miller CR, Oliver KE, Farley JH. 2014. MEK1/2 inhibitors in the treatment of gynecologic malignancies. Gynecol Oncol. 133:128–37. doi:10.1016/j.ygyno.2014.01.008.

Riahi R, Yang YL, Kim H, Jiang L, Wong PK, Zohar Y. 2014. A microfluidic model for organ-specific extravasation of circulating tumor cells. Biomicrofluidics. 8:024103. doi:10.1063/1.4868301.

Hatcher-Keller J, Rayens MK, Dignan M, Schoenberg N, Allison P. 2014. Beliefs regarding mammography screening among women visiting the emergency department for nonurgent care. J Emerg Nurs. 40:e27–35. doi:10.1016/j.jen.2013.01.015.

Weinstein RS, López AM, Joseph BA, Erps KA, Holcomb M, Barker GP, Krupinski EA. 2014. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 127:183–7. doi:10.1016/j.amjmed.2013.09.032.

Cusanovich DA, Pavlovic B, Pritchard JK, Gilad Y. 2014. The functional consequences of variation in transcription factor binding. PLoS Genet. 10:e1004226. doi:10.1371/journal.pgen.1004226.

Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA. 2014. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev. 23:255–73. doi:10.1158/1055-9965.EPI-13-0515.

Tredwell GD, Miller JA, Chow H-HS, Thompson PA, Keun HC. 2014. Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS. J Proteome Res. 13:883–9. doi:10.1021/pr400924k.

Garcia FAR, Cornelison T, Nuño T, Greenspan DL, Byron JW, Hsu C-H, Alberts DS, Chow H-HS. 2014. Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia. Gynecol Oncol. 132:377–82. doi:10.1016/j.ygyno.2013.12.034.

Zhao F, Malm SW, Hinchman AN, Li H, Beeks CG, Klimecki WT. 2014. Arsenite-induced pseudo-hypoxia results in loss of anchorage-dependent growth in BEAS-2B pulmonary epithelial cells. PLoS One. 9:e114549. doi:10.1371/journal.pone.0114549.

Dagher J, Reese T, Bilgin A. 2014. High-resolution, large dynamic range field map estimation. Magn Reson Med. 71:105–17. doi:10.1002/mrm.24636.

Watson JM, Marion SL, Rice PF, Bentley DL, Besselsen DG, Utzinger U, Hoyer PB, Barton JK. 2014. In vivo time-serial multi-modality optical imaging in a mouse model of ovarian tumorigenesis. Cancer Biol Ther. 15:42–60. doi:10.4161/cbt.26605.

Buchan JR. 2014. mRNP granules. Assembly, function, and connections with disease. RNA Biol. 11:1019–30. doi:10.4161/15476286.2014.972208.

Rogowitz E, Babiker HM, Kanaan M, Millius RA, Ringenberg QS, Bishop M. 2014. Neuroblastoma of the elderly, an oncologist’s nightmare: case presentation, literature review and SEER database analysis. Exp Hematol Oncol. 3:20. doi:10.1186/2162-3619-3-20.

Segrin C, Badger TA. 2014. Psychological and physical distress are interdependent in breast cancer survivors and their partners. Psychol Health Med. 19:716–23. doi:10.1080/13548506.2013.871304.

Mondal SB, Gao S, Zhu N, Liang R, Gruev V, Achilefu S. 2014. Real-time fluorescence image-guided oncologic surgery. Adv Cancer Res. 124:171–211. doi:10.1016/B978-0-12-411638-2.00005-7.

Megaraj V, Zhou X, Xie F, Liu Z, Yang W, Ding X. 2014. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model. Carcinogenesis. 35:131–7. doi:10.1093/carcin/bgt269.

Taverna JA, Babiker HM, Yun S, Bishop MC, Lau-Braunhut S, Meyer PN, Enzler T. 2014. The great masquerader of malignancy: chronic intestinal pseudo-obstruction. Biomark Res. 2:23. doi:10.1186/s40364-014-0023-y.

Larsen BT, Bishop MC, Hunter GC, Renner SW. 2013. Low-grade, metastasizing splenic littoral cell angiosarcoma presenting with hepatic cirrhosis and splenic artery aneurysm. Int J Surg Pathol. 21:618–26. doi:10.1177/1066896913476737.

Loescher LJ, Hansen C, Hepworth JT, Quale L, Sligh J. 2013. A preliminary study of a video intervention to inform solid organ transplant recipients about skin cancer. Transplant Proc. 45:3187–9. doi:10.1016/j.transproceed.2012.09.118.

Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, Glass CK. 2013. Effect of natural genetic variation on enhancer selection and function. Nature. 503:487–92. doi:10.1038/nature12615.

Hart MR, Su H-Y, Broka D, Goverdhan A, Schroeder JA. 2013. Inactive ERBB Receptors Cooperate With Reactive Oxygen Species To Suppress Cancer Progression. Molecular Therapy. 21(11):1996–2007. doi:10.1038/mt.2013.196.